Psychiatry & Neurology Doctors in Gladwyne, PA Accepting Medicare

4 Psychiatry & Neurology doctors found. Showing 1 - 4

Dr. Dale Eric Panzer, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1305 Lafayette Rd, Gladwyne, PA 19035 Phone: 610-651-0657    Fax: 610-722-0704

Dr. Joyce Zinsenheim, MD Psychiatry & Neurology - Sleep Medicine Medicare: Not Enrolled in Medicare Practice Location: 1509 Sweet Briar Rd, Gladwyne, PA 19035 Phone: 215-586-3703

Dr. Mary Ertlschweiger Geiger, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 205 Maple Hill Rd, Gladwyne, PA 19035 Phone: 610-896-5447    Fax: 610-896-6649

Dr. Jonathan Mark Raines, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1629 Monk Rd, Gladwyne, PA 19035 Phone: 610-649-8717

News Archive

Boston Scientific launches SCS lead splitters for use with Precision Plus Spinal Cord Stimulator System

Boston Scientific Corporation today announced U.S. Food and Drug Administration approval and launch of two spinal cord stimulation (SCS) lead splitters for use with its Precision Plus™ Spinal Cord Stimulator System, the world's first rechargeable SCS device for the management of chronic pain of the trunk, back and/or limbs.

ADIPOQ gene variations linked to colorectal cancer risk, new study reveals

Adiponectin, a collagen-like protein secreted by fat cells, derives from the ADIPOQ gene. Variations in this gene may increase risk for type 2 diabetes, cardiovascular disease, and various cancers. A new study that links specific variations in the ADIPOQ gene to either higher or lower colorectal cancer risk is published in Genetic Testing and Molecular Biomarkers, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

ResMed announces acquisition of Laboratoires Narval

ResMed Inc. (NYSE: RMD), a leading developer, manufacturer and distributor of sleep and respiratory medical equipment, announced today that it has acquired Laboratoires Narval. Based in France, Laboratoires Narval manufactures and distributes the Narval O.R.M.(TM), an innovative mandibular repositioning device (MRD) that offers a solution to patients for snoring and obstructive sleep apnea (OSA), especially for those with mild OSA.

China Medical Technologies fourth-quarter revenues down 29.3% to $25.7 million

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic company, today announced its unaudited financial results for the fourth fiscal quarter and the full fiscal year ended March 31, 2010.

New study evaluates effectiveness of weight loss surgery in individuals with obesity, diabetes

Researchers recently conducted the largest study to date to evaluate the effectiveness of weight loss surgery in a Chinese population of individuals with obesity and type 2 diabetes.

Read more Medical News

› Verified 3 days ago